A Prospective Randomized Phase II Study Evaluating the Monitoring of Imatinib Mesylate Plasmatic Through Level in Patients Newly Diagnosed With CP-CML

Clinical trial NCT02896842 · COMPLETED

Trial details

NCT number: NCT02896842
Sponsor: Versailles Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Start date: 2010-09-01
Primary completion: 2015-03-01
Enrollment: 139

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.